|
|
|
Volumn 18, Issue 3, 1998, Pages 71-80
|
|
Glycine therapy of schizophrenia; its rationale and a review of clinical trials
|
|
Author keywords
D cycloserine; Glycine; Glycine transporter; Negative symptoms; Schizophrenia
|
|
Indexed keywords
CYCLOSERINE;
DOPAMINE;
DOPAMINE 2 RECEPTOR;
GLUTAMIC ACID;
GLYCINE;
GLYCINE RECEPTOR AGONIST;
MILACEMIDE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NEUROLEPTIC AGENT;
PHENCYCLIDINE;
PRODRUG;
CLINICAL TRIAL;
HUMAN;
HYPOTHESIS;
NEGATIVE SYNDROME;
REVIEW;
SCHIZOPHRENIA;
ACETAMIDES;
ALANINE;
AMINO ACID TRANSPORT SYSTEMS, NEUTRAL;
ANIMALS;
CARRIER PROTEINS;
CYCLOSERINE;
GLUTAMIC ACID;
GLYCINE;
GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS;
HUMANS;
PRODRUGS;
RECEPTORS, GLYCINE;
RECEPTORS, N-METHYL-D-ASPARTATE;
SCHIZOPHRENIA;
SERINE;
|
|
EID: 0031668705
PISSN: 13402544
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (63)
|
